IP Library › Granted Patent US 12,427,517
Granted Patent B2
US 12,427,517 · App. 17/725,076 · Granted Sep 30, 2025

Microfluidic devices and methods incorporating assay units with multiple 3D scaffold regions

Inventors: Mehdi Nikkhah (Scottsdale, AZ); Ouse Sheblak (Scottsdale, AZ)
Assignee: Arizona Board of Regents on behalf of Arizona State University
B01L3/502715B01L2200/027B01L2200/0647B01L2300/0819
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,427,517
App. No.
17/725,076
Granted
Sep 30, 2025
Kind
B2
Abstract

A microfluidic device includes multiple microfluidic assay units arranged on a substrate, with each assay unit including multiple scaffold regions each containing a three-dimensional scaffold with associated cells, and a media channel surrounding a fluid-permeable boundary portion of at least a second scaffold region, wherein a fluid-permeable interface between the media channel and the second scaffold region comprises a curved shape spanning an arc of more than 90 degrees. A third scaffold region may be provided. Boundaries between different scaffold regions, and between a scaffold region and the media channel, may include microposts that may be spaced apart in a curved configuration. A method for performing an assay utilizing such a device is further provided.

Claims (61)

1. A microfluidic device comprising:

a substrate; and

a plurality of microfluidic assay units arranged on the substrate, wherein each microfluidic assay unit of the plurality of microfluidic assay units comprises:

a first scaffold region containing a first three-dimensional scaffold comprising one or more first cells;

a second scaffold region containing a second three-dimensional scaffold comprising one or more second cells, wherein the second scaffold region surrounds, and is in contact with, a fluid-permeable boundary portion of the first scaffold region; and

a media channel surrounding a fluid-permeable boundary portion of the second scaffold region, and permitting fluid communication between contents of the media channel and at least the second scaffold region, wherein a fluid-permeable interface between the media channel and the second scaffold region comprises a curved shape spanning an arc of more than 90 degrees.

2. The microfluidic device of claim 1 , wherein:

each microfluidic assay unit further comprises:

a first inlet port in fluid communication with the first scaffold region;

a second inlet port and a second outlet port in fluid communication with the second scaffold region; and

a media channel inlet port and a media channel outlet port in fluid communication with the media channel; and

each microfluidic assay unit, including a respective first scaffold region, second scaffold region, media channel, first inlet port, second outlet port, media channel inlet port, and media channel outlet port, is arranged within a circular footprint.

3. The microfluidic device of claim 2 , wherein microfluidic assay units of the plurality of microfluidic assay units are arranged on the substrate in a two-dimensional array, with the circular footprint of each microfluidic assay unit being spaced apart from the circular footprint of each other microfluidic assay unit of the plurality of microfluidic assay units.

4. The microfluidic device of claim 1 , wherein:

for each microfluidic assay unit, the media channel comprises an inlet segment coupled with the media channel inlet port, an outlet segment coupled with the media channel outlet port, and a main segment arranged between the inlet segment and the outlet segment; and

the main segment comprises a greater width than each of the inlet segment and the outlet segment.

5. The microfluidic device of claim 4 , wherein the main segment contacts the fluid-permeable boundary portion of the second three-dimensional scaffold region.

6. The microfluidic device of claim 4 , wherein for each microfluidic assay unit, the main segment comprises a substantially constant width.

7. The microfluidic device of claim 5 , wherein for each microfluidic assay unit, the main segment comprises a semi-annular shape.

8. The microfluidic device of claim 1 , wherein each microfluidic assay unit further comprises:

a plurality of first microposts arranged between the first scaffold region and the second scaffold region; and

a plurality of second microposts arranged at a boundary of the second scaffold region, and arranged between the second scaffold region and the media channel.

9. The microfluidic device of claim 1 , wherein the first three-dimensional scaffold and the second three-dimensional scaffold each comprise a hydrogel.

10. The microfluidic device of claim 1 , wherein for each microfluidic assay unit, the fluid-permeable interface between the media channel and the second scaffold region comprises a curved shape spanning an arc of at least 135 degrees.

11. The microfluidic device of claim 1 , wherein for each microfluidic assay unit, the fluid-permeable interface between the media channel and the second scaffold region comprises a curved shape spanning an arc of at least 180 degrees.

12. The microfluidic device of claim 1 , wherein for each microfluidic assay unit:

the one or more first cells comprises at least one of migratory cells, stem cells, and tumor cells; and

the one or more second cells comprises at least one of: adipocytes, fibroblasts, macrophages, T-cells, and monocytes.

13. The microfluidic device of claim 1 , wherein:

each microfluidic assay unit further comprises a third scaffold region containing a third three-dimensional scaffold comprising one or more third cells, wherein the third scaffold region surrounds, and is in contact with, the fluid-permeable boundary portion of the second scaffold region; and

for each microfluidic assay unit, the third scaffold region is arranged between the second scaffold region and the media channel, wherein the fluid-permeable interface between the media channel and the second scaffold region includes a portion of the third scaffold region.

14. The microfluidic device of claim 13 , further comprising:

a plurality of first microposts arranged between the first scaffold region and the second scaffold region;

a plurality of second microposts arranged between the second scaffold region and the third scaffold region; and

a plurality of third microposts arranged between the third scaffold region and the media channel.

15. The microfluidic device of claim 13 , wherein for each microfluidic assay unit:

the one or more first cells comprises at least one of migratory cells, stem cells, and tumor cells;

the one or more second cells comprises at least one of adipocytes and fibroblasts; and

the one or more third cells comprises at least one of macrophages, T-cells, monocytes, vascular cells, endothelial cells, smooth muscle cells, and pericytes.

16. A method for performing an assay utilizing a microfluidic device that comprises a substrate and a plurality of microfluidic assay units arranged on the substrate, wherein each microfluidic assay unit comprises (i) a first scaffold region, (ii) a second scaffold region containing a second three-dimensional scaffold comprising one or more second cells, wherein the second scaffold region surrounds, and is in contact with, a fluid-permeable boundary portion of the first scaffold region, and (iii) a media channel surrounding a fluid-permeable boundary portion of the second scaffold region, wherein a fluid-permeable interface between the media channel and the second scaffold region comprises a curved shape spanning an arc of more than 90 degrees, the method comprising:

forming a first three-dimensional scaffold comprising a plurality of first cells in the first scaffold region;

forming a second three-dimensional scaffold comprising a plurality of second cells in the second scaffold region; and

supplying liquid media to the media channel to permit fluid communication between contents of the media channel and at least the second scaffold region.

17. The method of claim 16 , further comprising, for each microfluidic assay unit, extracting liquid media from the media channel, and analyzing the extracted liquid media.

18. The method of claim 16 , further comprising, for each microfluidic assay unit:

digesting at least a portion of the first three-dimensional scaffold in the first scaffold region;

removing at least some first cells of the plurality of first cells from the digested first three-dimensional scaffold of the first scaffold region; and

analyzing the at least some first cells.

19. The method of claim 16 , further comprising, for each microfluidic assay unit:

digesting at least a portion of the second three-dimensional scaffold in the second scaffold region;

removing at least some second cells of the plurality of second cells from the digested second three-dimensional scaffold of the second scaffold region; and

analyzing the at least some second cells.

20. The method of claim 16 , wherein:

each microfluidic assay unit further comprises (iv) a third scaffold region that surrounds, and is in contact with, the fluid-permeable boundary portion of the second scaffold region, with the third scaffold region arranged between the second scaffold region and the media channel, and with the fluid-permeable interface between the media channel and the second scaffold region including a portion of the third scaffold region;

the method further comprises forming a third three-dimensional scaffold comprising a plurality of third cells in the third scaffold region; and

the supplying of liquid media to the media channel permits fluid communication between contents of the media channel and at least the second scaffold region through the third scaffold region.

21. The method of claim 20 , further comprising, for each microfluidic assay unit:

digesting at least a portion of the third three-dimensional scaffold in the third scaffold region;

removing at least some third cells of the plurality of third cells from the digested third three-dimensional scaffold of the third scaffold region; and

analyzing the at least some third cells.

22. The method of claim 16 , further comprising performing imaging analysis of at least a portion of each microfluidic assay unit.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2022
From: NIKKHAH, MEHDI; SHEBLAK, OUSE
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 059667/0102 →
Continuity (2)
Provisional Application 63178334 · Apr 22, 2021
Related Publication 20220339629A1 · Oct 27, 2022
References Cited (12)
US 7371400B2 · Borenstein · 2008 [cited by examiner]
US 8343740B2 · Gonda · 2013 [cited by examiner]
US 10017724B2 · Nikkhah et al. · 2018 [cited by applicant]
US 10712339B2 · Nikkhah et al. · 2020 [cited by applicant]
US 20120003732A1 · Hung · 2012 [cited by examiner]
US 20130143230A1 · Tolias · 2013 [cited by examiner]
US 20160152945A1 · Blahut · 2016 [cited by examiner]
US 20180105793A1 · Pathak · 2018 [cited by examiner]
US 20200326330A1 · Kundu · 2020 [cited by examiner]
Feng, J. et al., “An in situ Raman spectroscopy-based microfluidic “lab-on-a-chip” platform for non-destructive and continuous characterization of Pseudomonas aeruginosa biofilms,” Chemical Communications, vol. 51, Apr.… [cited by applicant]
Truong, D. et al., “Breast Cancer Cell Invasion into a Three Dimensional Tumor-Stroma Microenvironment,” Scientific Reports, vol. 6, Article No. 34094, Sep. 2016, 18 pages. [cited by applicant]
Zhang, Z., et al., “An ROS-sensitive tegafur-PpIX-heterodimerloaded in situ injectable thermosensitive hydrogel for photodynamic therapy combined with chemotherapy to enhance the tegafur-based treatment of breast cancer… [cited by applicant]